Lineage Cell Therapeutics, Inc. (LCTX)

Import this data to Google Sheets with:

=jivedata("LCTX","financials")

Full statements spill as a table. For one cell: =jivedata("LCTX","Revenue") or =jivedata("LCTX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Lineage Cell Therapeutics, Inc.

LCTX • CIK 0000876343

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenues	$8,945	$9,499	$14,556	$13,083
Cost of Revenue	$671	$334	—	$272
Gross Profit	$8,274	—	—	$8,274
Operating Expenses	$33,007	—	—	$33,007
Research and Development Expense	$15,705	$12,472	$17,729	$20,517
Operating Income (Loss)	$-24,733	$-21,478	$-36,619	$-26,850
Interest Income (Expense), Nonoperating, Net	$1,629	$1,715	$1,691	$1,542
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-23,282	$-18,582	$-68,647	$-68,647
Income Tax Expense (Benefit)	$-1,803	$0	$-5,280	$-5,280
Net Income (Loss) Attributable to Parent	$-21,486	$-18,609	$-63,533	$-32,260

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Assets	$101,019	$113,218	$112,584	$106,220
Liabilities	$38,996	$36,206	$69,238	$46,422
Assets, Current	$38,441	$50,997	$59,157	$52,970
Cash and Cash Equivalents, at Carrying Value	$35,442	$45,789	$40,791	$37,355
Accounts Receivable, after Allowance for Credit Loss, Current	$745	$638	$891	$790
Property, Plant and Equipment, Net	$4,767	$2,251	$2,566	$2,517
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$7,238	$4,384	$5,684	$6,100
Operating Lease, Right-of-Use Asset	—	$2,144	$2,131	$1,964
Goodwill	$10,672	$10,672	$10,672	$10,672
Intangible Assets, Net (Excluding Goodwill)	$46,562	$46,540	$31,700	$31,700
Deferred Tax Assets, Net of Valuation Allowance	$4,725	$7,114	$20,105	$20,105
Liabilities, Current	$17,960	$13,977	$11,367	$8,016
Accounts Payable, Current	$2,050	$1,174	$2,341	$1,536
Accrued Liabilities, Current	$1,097	$1,197	$1,096	$1,002
Stockholders' Equity Attributable to Parent	$63,419	$78,381	$44,549	$60,916

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Cash Provided by (Used in) Operating Activities	$-28,566	$-23,092	$-18,919	$-23,816
Net Cash Provided by (Used in) Investing Activities	$46,449	$-2,308	$-13,457	$-13,712
Net Cash Provided by (Used in) Financing Activities	$6,423	$35,857	$26,950	$32,240
Depreciation, Depletion and Amortization, Nonproduction	$562	$587	$699	$739
Payments to Acquire Property, Plant, and Equipment	$674	$565	$522	$574
Proceeds from Issuance of Common Stock	$6,625	—	—	$14,070

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("LCTX","financials")

Full statements spill as a table. For one cell: =jivedata("LCTX","Revenue") or =jivedata("LCTX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.